REG - BioPharma Credit PLC - Director Declaration

Biopharma CreditAnnouncement

14/11/2024 17:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241114:nRSN3325Ma&default-theme=true

RNS Number : 3325M  BioPharma Credit PLC  14 November 2024

BioPharma Credit PLC (the "Company")

 

Director Declaration

 

In accordance with paragraph 6.4.9 R of the UK Listing Rules, the Company has
been informed that Colin Bond, Non-executive Director of the Company, has been
appointed as a director of Formycon AG with effect from 1 October 2024.

 

 

14 November 2024

 

LEI: 213800AV55PYXAS7SY24

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNBIBRTMTJBBPI